Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Thoracic Malignancies × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2382 Carcinoma, Non-Small-Cell Lung 1927 Prostatic Neoplasms 1248 Colorectal Neoplasms 1108 Neoplasms 1058 Multiple Myeloma 918 Lung Neoplasms 896 Neoplasm Metastasis 861 Leukemia, Myeloid, Acute 835 Lymphoma 766 Melanoma 751 Pancreatic Neoplasms 708 Ovarian Neoplasms 686 Carcinoma, Hepatocellular 661 Recurrence 652 Stomach Neoplasms 651 Leukemia 641 Lymphoma, Non-Hodgkin 586 Leukemia, Lymphocytic, Chronic, B-Cell 562 Squamous Cell Carcinoma of Head and Neck 534 Lymphoma, Large B-Cell, Diffuse 533 Precursor Cell Lymphoblastic Leukemia-Lymphoma 516 Head and Neck Neoplasms 515 Brain Neoplasms 512 Glioblastoma 499 Carcinoma, Renal Cell 498 Rectal Neoplasms 489 Myelodysplastic Syndromes 449 Sarcoma 442 Lymphoma, Follicular 438

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03732430 2018-11-29

CARTAI

Taizhou Hospital

Phase 2 Unknown

Thoracic Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡